About Us

At TAE Life Sciences, our mission is to advance BNCT and investigate its potential as a promising treatment for broad clinical use. The foundation of our revolutionary pathway to treatment is an accelerator-based neutron beam, derived from decades of groundbreaking work by TAE Technologies, Inc., an innovative leader in fusion energy technology.

Leveraging these advances, TAE Life Sciences is developing a holistic clinical platform for the next generation of BNCT: low energy neutron beams capable of catering to unique clinical treatment protocols with the ability to tune beam intensity, coupled with a practical footprint for hospitals or free-standing radiation treatment settings.

We have assembled a world-class, cross-functional team of clinicians, radiation oncologists, physicists and other researchers to enable us to bring our technology to those who need it the most.